MAb therapy against the IFN-alpha/beta receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden

Paul F. A. Teunissen, Marieke C. Boshuizen, Maurits R. Hollander, Paul. S. Biesbroek, Nina W. van der Hoeven, Jan-Quinten Mol, Marion J. Gijbels, Saskia van der Velden, Tineke C. van der Pouw Kraan, Anton J. Horrevoets, Menno P. de Winther, Niels van Royen

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)255-266
JournalCardiovascular Research
Volume107
Issue number2
DOIs
Publication statusPublished - 15 Jul 2015

Keywords

  • Collateral circulation
  • Atherosclerosis
  • MAbs
  • Animal model cardiovascular disease
  • Cytokine

Cite this

Teunissen, P. F. A., Boshuizen, M. C., Hollander, M. R., Biesbroek, P. S., van der Hoeven, N. W., Mol, J-Q., Gijbels, M. J., van der Velden, S., Kraan, T. C. V. D. P., Horrevoets, A. J., de Winther, M. P., & van Royen, N. (2015). MAb therapy against the IFN-alpha/beta receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden. Cardiovascular Research, 107(2), 255-266. https://doi.org/10.1093/cvr/cvv138